comparemela.com

Page 2 - Nyse Che News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chemed (NYSE:CHE) Releases FY24 Earnings Guidance

Chemed (NYSE:CHE – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $23.30-23.70 for the period, compared to the consensus estimate of $23.52. Chemed also updated its FY 2024 guidance to 23.300-23.700 EPS. Chemed Stock Performance Shares of Chemed stock traded down $9.40 on Friday, […]

Chemed (NYSE:CHE) Stock Price Down 7 2% Following Weak Earnings

Chemed Co. (NYSE:CHE – Get Free Report)’s stock price traded down 7.2% during trading on Thursday after the company announced weaker than expected quarterly earnings. The stock traded as low as $561.00 and last traded at $573.47. 71,152 shares changed hands during trading, a decline of 8% from the average session volume of 77,294 shares. […]

Chemed (NYSE:CHE) Updates FY24 Earnings Guidance

Chemed (NYSE:CHE – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $23.30-23.70 for the period, compared to the consensus earnings per share estimate of $23.52. Chemed also updated its FY 2024 guidance to 23.300-23.700 EPS. Chemed Stock Down 6.9 % Shares […]

Chemed (NYSE:CHE) Issues FY24 Earnings Guidance

Chemed (NYSE:CHE – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $23.30-23.70 for the period, compared to the consensus earnings per share estimate of $23.52. Chemed also updated its FY 2024 guidance to 23.300-23.700 EPS. Chemed Trading Down 6.9 % Shares […]

Analyzing BrightSpring Health Services (NASDAQ:BTSG) and Chemed (NYSE:CHE)

Chemed (NYSE:CHE – Get Free Report) and BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, earnings, institutional ownership, risk, analyst recommendations and valuation. Institutional and Insider Ownership 95.9% of Chemed shares […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.